Back to Trades
Hagerman Allison
Chief Technology OfficerCIK 0002103583
Profile
- Filings
- 2
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 2 filings between 2026, Hagerman Allison, Chief Technology Officer, has disclosed $8.3K in transactions — all concentrated in ONCOLYTICS BIOTECH INC (ONCY). Their disclosed trades are heavily weighted toward buying — $8.3K in buys and $0 in sells. The largest single open-market purchase on record is $8.3K in ONCOLYTICS BIOTECH INC. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 3 | ONCY ONCOLYTICS BIOTECH INC | Hagerman Allison | Chief Technology Officer | Award | $0 |
| Feb 13 | ONCY ONCOLYTICS BIOTECH INC | Hagerman Allison | VP, Product Development | Buy | $8.3K |
2 filings